CIK 0000072444 · Accelerated filer<br>Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 591212264
- Phone
- (650) 550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-24 | Cummings James F. Chief Medical Officer | Shares withheld for taxes | −30,551 | $0.69 | $21K | 927,469 |
| 2026-03-24 | Lo Steven President, Chief Exec Officer | Shares withheld for taxes | −126,028 | $0.69 | $87K | 2,485,606 |
| 2026-03-24 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −36,418 | $0.69 | $25K | 886,735 |
| 2026-03-18 | Berg Edward B SVP, General Counsel | Shares withheld for taxes | −8,072 | $0.63 | $5K | 791,786 |
| 2026-03-18 | Cummings James F. Chief Medical Officer | Shares withheld for taxes | −6,772 | $0.63 | $4K | 958,020 |
| 2026-03-18 | Lo Steven President, Chief Exec Officer | Shares withheld for taxes | −22,425 | $0.63 | $14K | 2,611,634 |
| 2026-03-18 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −8,072 | $0.63 | $5K | 923,153 |
| 2026-03-16 | Lo Steven President, Chief Exec Officer | Grant or award | +846,500 | 2,634,059 | ||
| 2026-03-16 | Lo Steven President, Chief Exec Officer | Grant or award · Stock Option (right to buy) | +1,543,000 | 1,543,000 | ||
| 2026-03-16 | Tucker Sean SVP, Chief Scientific Officer | Grant or award | +200,000 | 931,225 | ||
| 2026-03-16 | Tucker Sean SVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +410,000 | 410,000 | ||
| 2026-03-16 | Grasman Jeroen Nicolaas Chief Financial Officer | Grant or award | +227,000 | 577,000 | ||
| 2026-03-16 | Grasman Jeroen Nicolaas Chief Financial Officer | Grant or award · Stock Option (right to buy) | +455,000 | 455,000 | ||
| 2026-03-16 | Cummings James F. Chief Medical Officer | Grant or award | +227,000 | 964,792 | ||
| 2026-03-16 | Cummings James F. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +455,000 | 455,000 | ||
| 2026-03-16 | Berg Edward B SVP, General Counsel | Grant or award | +115,000 | 799,858 | ||
| 2026-03-16 | Berg Edward B SVP, General Counsel | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2026-02-02 | Cummings James F. Chief Medical Officer | Shares withheld for taxes | −7,965 | $0.61 | $5K | 737,792 |
| 2026-02-02 | Berg Edward B SVP, General Counsel | Shares withheld for taxes | −9,265 | $0.61 | $6K | 684,858 |
| 2026-02-02 | Tucker Sean SVP, Chief Scientific Officer | Shares withheld for taxes | −9,265 | $0.61 | $6K | 731,225 |
Page 2 of 10 · 198 trades